All In MedTech

Device Trial Radar · NCT01348581

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins

Last checked: Nov 19, 2026Latest source record: Mar 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

37

Actual

Start

Nov 2010

Primary completion

Dec 2012

Study completion Jan 1, 2013

Sponsor

Lead sponsor
Kerecis Ltd.Not on our public-company list
Sponsor type
Industry
First posted
May 5, 2011

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The clinical study is designed to assess the effectiveness, safety and non-immunogenicity of fish skin wound dressing extracellular matrix (ECM) in treating chronic wounds. The wound dressing is indicated for the management of difficult to heal and chronic wounds. The matrix is cut to fit the wound and is applied to the wound bed. An absorptive secondary dressing is put on top. Further dressing of the wound depends on the etiology. The indications for use are: * partial and full-thickness wounds * pressure ulcers * venous ulcers * diabetic ulcers * chronic vascular ulcers * tunneled/undermined wounds * trauma wounds (abrasions, lacerations, second-degree burns, and skin tears)

Conditions

  • Pressure Ulcers
  • Venous Ulcers
  • Diabetic Ulcers
  • Chronic Ulcer of Foot
  • Trauma-related Wound

Interventions

  • Marigen Wound DressingDevice

    The dressing is changed at least twice a week, with no more than five days between dressing changes. It is extremely important that the dressings are changed sufficiently often. On highly exuding ulcers the three or four dressing changes per week may be necessary. Duration is four weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wound healingTime frame: one year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • National University Hospital

    Reykjavik, Iceland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.